1. Home
  2. NISN vs SYBX Comparison

NISN vs SYBX Comparison

Compare NISN & SYBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NISN
  • SYBX
  • Stock Information
  • Founded
  • NISN 2005
  • SYBX N/A
  • Country
  • NISN China
  • SYBX United States
  • Employees
  • NISN N/A
  • SYBX N/A
  • Industry
  • NISN Metal Fabrications
  • SYBX Biotechnology: Pharmaceutical Preparations
  • Sector
  • NISN Industrials
  • SYBX Health Care
  • Exchange
  • NISN Nasdaq
  • SYBX Nasdaq
  • Market Cap
  • NISN 19.6M
  • SYBX 16.4M
  • IPO Year
  • NISN 2016
  • SYBX N/A
  • Fundamental
  • Price
  • NISN $3.91
  • SYBX $1.38
  • Analyst Decision
  • NISN
  • SYBX
  • Analyst Count
  • NISN 0
  • SYBX 0
  • Target Price
  • NISN N/A
  • SYBX N/A
  • AVG Volume (30 Days)
  • NISN 32.5K
  • SYBX 103.1K
  • Earning Date
  • NISN 04-29-2025
  • SYBX 08-19-2025
  • Dividend Yield
  • NISN N/A
  • SYBX N/A
  • EPS Growth
  • NISN N/A
  • SYBX N/A
  • EPS
  • NISN 1.43
  • SYBX N/A
  • Revenue
  • NISN $340,219,546.00
  • SYBX N/A
  • Revenue This Year
  • NISN N/A
  • SYBX N/A
  • Revenue Next Year
  • NISN N/A
  • SYBX N/A
  • P/E Ratio
  • NISN $17.73
  • SYBX N/A
  • Revenue Growth
  • NISN 8.05
  • SYBX N/A
  • 52 Week Low
  • NISN $3.22
  • SYBX $0.90
  • 52 Week High
  • NISN $22.55
  • SYBX $1.96
  • Technical
  • Relative Strength Index (RSI)
  • NISN 44.89
  • SYBX 45.87
  • Support Level
  • NISN $3.85
  • SYBX $1.33
  • Resistance Level
  • NISN $4.32
  • SYBX $1.96
  • Average True Range (ATR)
  • NISN 0.32
  • SYBX 0.11
  • MACD
  • NISN -0.02
  • SYBX -0.03
  • Stochastic Oscillator
  • NISN 5.71
  • SYBX 12.82

About NISN NiSun International Enterprise Development Group Co. Ltd.

NiSun International Enterprise Development Group Co Ltd is a provider of supply chain solutions and integrated financial services. Nisun is dedicated to providing professional supply chain solutions to Chinese and foreign enterprises and financial institutions. Through its subsidiaries, it is engaged in delivering supply chain solutions, and supply chain trading services to its customers across different industries. The company also provides financial solutions to small and mid-sized enterprises within the supply chain ecosystem. Using its fintech platforms, it provides various financing options, including supply chain financing, trade financing, and receivables financing. Geographically, its operations are predominantly focused on markets within the People's Republic of China.

About SYBX Synlogic Inc.

Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.

Share on Social Networks: